#precision-medicine

[ follow ]
#ai-in-healthcare

This AI Model Could Keep Thousands Of Cancer Patients From Getting Unnecessary Treatments

Ataraxis has developed an AI test to precisely differentiate between high-risk and low-risk breast cancer, potentially reducing unnecessary chemotherapy treatments.

Aignostics secures 31M from ATHOS, HTGF, others - Silicon Canals

Aignostics raised $34M to enhance AI capabilities in pathology, targeting improvements in diagnostics and collaborations with major healthcare institutions.

Valar Labs debuts AI-powered cancer care prediction tool and secures $22M | TechCrunch

AI in healthcare, like Valar Labs' Vesta tool, aims to predict treatment outcomes accurately, saving time for patients with specific cancers.

This AI Model Could Keep Thousands Of Cancer Patients From Getting Unnecessary Treatments

Ataraxis has developed an AI test to precisely differentiate between high-risk and low-risk breast cancer, potentially reducing unnecessary chemotherapy treatments.

Aignostics secures 31M from ATHOS, HTGF, others - Silicon Canals

Aignostics raised $34M to enhance AI capabilities in pathology, targeting improvements in diagnostics and collaborations with major healthcare institutions.

Valar Labs debuts AI-powered cancer care prediction tool and secures $22M | TechCrunch

AI in healthcare, like Valar Labs' Vesta tool, aims to predict treatment outcomes accurately, saving time for patients with specific cancers.
moreai-in-healthcare
#cancer-research

Improving the Science and Treatment of Glioblastoma - News Center

Glioblastoma remains highly aggressive with stagnated survival rates, highlighting the need for new treatment strategies.

Cancer AI Alliance joins medical and tech expertise together with $40M to collaborate on next-gen care | TechCrunch

The Cancer AI Alliance seeks to leverage AI for collaboration among major cancer institutions to improve patient outcomes.
Federated learning is vital to securely and efficiently share medical data between member institutions.

Improving the Science and Treatment of Glioblastoma - News Center

Glioblastoma remains highly aggressive with stagnated survival rates, highlighting the need for new treatment strategies.

Cancer AI Alliance joins medical and tech expertise together with $40M to collaborate on next-gen care | TechCrunch

The Cancer AI Alliance seeks to leverage AI for collaboration among major cancer institutions to improve patient outcomes.
Federated learning is vital to securely and efficiently share medical data between member institutions.
morecancer-research

Study identifies five different ways of aging thanks to data from 50,000 brain scans

Machine learning reveals subtle brain aging patterns, offering personalized insights for understanding aging and neurodegenerative diseases.
#funding

German healthtech startup Lucid Genomics secures 1.3M

Lucid Genomics has raised €1.3M to enhance their AI-driven platform for comprehensive genetic insight, targeting improvements in drug discovery and disease diagnostics.

Phenomix Sciences Raises $7.8M in Funding to Accelerate Adoption of Obesity Precision Medicine

Phenomix Sciences secured $7.8 million funding for precision medicine in obesity to accelerate commercialization and adoption of MyPhenome test.

German healthtech startup Lucid Genomics secures 1.3M

Lucid Genomics has raised €1.3M to enhance their AI-driven platform for comprehensive genetic insight, targeting improvements in drug discovery and disease diagnostics.

Phenomix Sciences Raises $7.8M in Funding to Accelerate Adoption of Obesity Precision Medicine

Phenomix Sciences secured $7.8 million funding for precision medicine in obesity to accelerate commercialization and adoption of MyPhenome test.
morefunding

Investigators Discover New Therapeutic Target for Pediatric Brain Cancers - News Center

Targeting TIM3 protein may enhance survival in pediatric brain cancer treatments, specifically low-grade astrocytoma, presenting a potential new therapeutic option.

Does your brain reflect your sex? - Harvard Gazette

Precision medicine is just one field where the answer matters

How precision medicine is tackling stubborn cancers in 2024

Cancer cases and deaths are projected to increase significantly by 2040 despite advancements in treatment.
Precision medicine offers personalized cancer treatment by targeting specific mutations, maximizing effectiveness, and minimizing side effects.

Pure nanodiamonds with quantum technology set to predict disease with unprecedented accuracy

Quantum sensors show promise in precision and preventive medicine.

NIMH Research and Science Track at 2024 APA Annual Meeting

National Institute of Mental Health (NIMH) hosts the Research and Science track at the 2024 APA Annual Meeting, focusing on addiction and mental health research.

Metabolon Secures $60M Credit Facility to Accelerate Growth Initiatives

Metabolon secured $60M credit facility from Trinity Capital, enabling growth in R&D, global expansion for metabolomics solutions in life sciences.

Precision Medicine Has a Data Equity Problem - Non Profit News | Nonprofit Quarterly

Precision medicine has the potential to rectify healthcare inefficiencies and disparities, but current disparities in genomic data may perpetuate inequality.
Precision medicine has led to improved treatments for rare diseases, advancements in cancer care, and revolutionized prenatal genetic testing.

Researchers are figuring out how African ancestry can affect certain brain disorders

Genomic studies lacked data on Black Americans' neurological disorders, leading to the creation of the African Ancestry Neuroscience Research Initiative in Baltimore.

NHS gene check is helping children with cancer

Whole genome sequencing (WGS) improves children's cancer treatment by identifying cancer-causing mutations, guiding precise medicine selection, and assessing familial cancer risks.

From data to drugs: How AI is revolutionising drug development

AI is transforming drug discovery through automation and precision, moving from artisanal to data-driven processes.
[ Load more ]